Alimentary Pharmacology & Therapeutics, 0269-2813

Journal

1 - 10 out of 72Page size: 10

Publications

  1. 2021
  2. Published

    The risk of later surgery at the anastomotic site following right hemicolectomy for Crohn’s disease in a national cohort of 12 230 patients

    Nicola Adderley, Raoul Reulen, Prashant Patel, Jan 2021, In: Alimentary Pharmacology & Therapeutics. 53, 1, p. 114-127 14 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2020
  4. Published

    Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom

    Mohammed Nabil Quraishi, Sep 2020, In: Alimentary Pharmacology & Therapeutics. 52, 5, p. 937-939 3 p.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Review article: chronic liver disease and pregnancy

    Abhishek Chauhan, 1 Aug 2020, In: Alimentary Pharmacology & Therapeutics. 52, 3, p. 420-429

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Letter: faecal microbiota transplantation for IBS

    Mohammed Nabil Quraishi & Tariq Iqbal, Aug 2020, In: Alimentary Pharmacology & Therapeutics. 52, 3, p. 556-557 2 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study

    Benjamin Fisher, Fang Gao Smith, Aug 2020, In: Alimentary Pharmacology & Therapeutics. 52, 3, p. 449-458

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic—authors' reply

    Nicola Adderley, Jun 2020, In: Alimentary Pharmacology & Therapeutics. 51, 12, p. 1442-1443 2 p.

    Research output: Contribution to journal › Editorial › peer-review

  9. Published

    Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis?

    Philip Newsome, May 2020, In: Alimentary Pharmacology & Therapeutics.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018

    Raoul Reulen, Rasiah Thayakaran, Anuradhaa Subramanian, Krishna Gokhale, Krishnarajah Nirantharakumar, Nicola Adderley, 27 Apr 2020, In: Alimentary Pharmacology & Therapeutics. 51, 10, p. 922-934

    Research output: Contribution to journal › Article › peer-review

  11. E-pub ahead of print

    Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome

    Angela Taylor, Lorna Gilligan, Zaki Hassan-Smith, Jane Grove, Wiebke Arlt & 1 others, Jeremy Tomlinson, 16 Apr 2020, In: Alimentary Pharmacology & Therapeutics.

    Research output: Contribution to journal › Article › peer-review

  12. Published

    Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome.

    Lorna Gilligan, Zaki Hassan-Smith, Apr 2020, In: Alimentary Pharmacology & Therapeutics.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 8 Next